Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

240 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

ITALY

EMILIA ROMAGNA
MELDOLA

Recruiting trial
Ongoing trial
LUTHREE - Randomized Phase II Trial in sstr2 Positive Tumors to Optimize the Interval Between Cycles of PRRT With 177lu-dotatate Study
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
UO Medicina Nucleare

ITALY

LAZIO
ROMA

Recruiting trial
Ongoing trial
A Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and/or Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
Ambulatorio Polispecialistico per le Malattie Rare

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

BELGIUM

VLAAMS BRABANT
LEUVEN

Recruiting trial
Ongoing trial
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors: a First-in-human PET/CT Study
University Hospitals Leuven - Gasthuisberg
Nuclear medicine and molecular imaging

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
Phase II Study on the Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy
CLCC Institut Curie
Département d'Oncologie pédiatrique, adolescents et jeunes adultes

GERMANY

Bayern
ERLANGEN

Ongoing trial
TELEPATH: A Multicenter, Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (Phase III ) - DE
Internistisches Zentrum des Universitätsklinikums Erlangen
Medizinische Klinik 1 - Gastroenterologie, Pneumologie und Endokrinologie

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
BERLIN

Ongoing trial
CSOM230D2203: An open label, multicentre, single arm phase II study of Pasireotide LAR in patients with Rare Tumors of Neuroendocrine Origin - DE
Charité - Universitätsmedizin Berlin (CCM)
Medizinische Klinik für Endokrinologie, Diabetes und Ernährungsmedizin

GERMANY

Thüringen
BAD BERKA

Recruiting trial
Ongoing trial
COMPETE: Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients -DE-
Zentralklinik Bad Berka GmbH
Zentrum für Neuroendokrine Tumoren Bad Berka

SWITZERLAND

Suisse Romande
ADDRESS: NOT PROVIDED - CH

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Somerset
BRISTOL

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

BELGIUM

VLAAMS BRABANT
LEUVEN

Ongoing trial
Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders - BE
University Hospitals Leuven - Gasthuisberg
Centrum metabole ziekten - UZ Leuven

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (Phase II) - DE
Nationales Centrum für Tumorerkrankungen (NCT)
AG Molekulare und Zelluläre Onkologie

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
PODIUM 201: A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma - DE
Westdeutsches Tumorzentrum Essen (WTZ)
Comprehensive Cancer Center (CCC) Essen

SPAIN

Cataluña
BARCELONA

Recruiting trial
Ongoing trial
PODIUM 201: A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma - ES
Hospital Universitari Vall d'Hebron
Servicio de Oncología médica

SPAIN

Madrid
MADRID

Ongoing trial
Setmelanotide (RM-493): Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Endocrinología, Crecimiento y Metabolismo

SWITZERLAND

Suisse Alémanique
ZÜRICH

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater London
NORTHWOOD

Recruiting trial
Ongoing trial
UKMCC-01: A Phase II Study of Pazopanib in Metastatic Merkel Cell Carcinoma
Mount Vernon Hospital
Mount Vernon Cancer Centre

UNITED KINGDOM

Greater London
SURREY

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Greater Manchester
MANCHESTER

UNITED KINGDOM

Merseyside
LIVERPOOL

Ongoing trial
Effects of exenatide on appetite and ghrelin levels in patients with Prader-Willi Syndrome
Fazakerley Hospital
University Hospital Aintree - Diabetes and Endocrinology

UNITED KINGDOM

Strathclyde
GLASGOW

UNITED KINGDOM

West Midlands
BIRMINGHAM

UNITED STATES

Texas
DALLAS

Ongoing trial
Funded by an IRDiRC memberPhase 2 Study of Orlistat and SLx-4090 for the treatment of Type 1 Hyperlipoproteinemia - US
University of Texas Southwestern Medical Center
Department of Internal Medicine

FRANCE

AUVERGNE-RHONE-ALPES
LYON

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
FIRSTMAPPP: First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma - FR
CLCC Institut Gustave Roussy
Cancers endocriniens - Surrénales et Tumeurs neuro-endocrines

GERMANY

Bayern
WÜRZBURG

Ongoing trial
Funded by an IRDiRC memberFIRSTMAPPP study: First international randomised phase II study in malignant progressive Pheochromocytoma and Paraganglioma - DE
Zentrum Innere Medizin (ZIM)
Medizinische Klinik und Poliklinik I - Endokrinologie und Diabetologie

SPAIN

Madrid
MADRID

Ongoing trial
Phase 1/2 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies - ES
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología

SWITZERLAND

Suisse Alémanique
BASEL

SWITZERLAND

Suisse Alémanique
BASEL

UNITED STATES

Pennsylvania
PHILADELPHIA

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCE

ILE-DE-FRANCE
PARIS

NETHERLANDS

Noord-Holland
AMSTERDAM

Ongoing trial
Microvascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Recruiting trial
Ongoing trial
RADS2: Combined Immunotherapy and Trophic Adrenocortical Stimulation in New Onset Autoimmune Addison's Disease
Institute of Genetic Medicine - International Centre for Life
Endocrine and Renal Genetics

UNITED STATES

New York
NEW YORK

Multinational clinical trial(s)

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

NORWAY

Vestlandet
BERGEN

Glucocorticoid Treatment in Addison's Disease
Haukeland University Hospital